RSS-Feed abonnieren
DOI: 10.1055/s-0031-1280377
© Georg Thieme Verlag KG Stuttgart · New York
Bioguided Isolation of (9Z)-Octadec-9-enoic Acid from Phellodendron amurense Rupr. and Identification of Fatty Acids as PTP1B Inhibitors
Publikationsverlauf
received August 10, 2011
revised October 14, 2011
accepted October 29, 2011
Publikationsdatum:
28. November 2011 (online)

Abstract
The therapy of type-2 diabetes mellitus is one of the major challenges of our age. A possible strategy to prevent the progression of this disease is the inhibition of protein tyrosine phosphatase 1B (PTP1B), a major negative regulator in the insulin and leptin signalling pathway. Phellodendri amurensis cortex is a well-known Asian herbal drug traditionally used as antiphlogistic, antibacterial, and anti-inflammatory agent, and its efficacy against diabetes-related symptoms is reported as well. However, information regarding active principle(s) or the molecular mode of action was scarce. By bioguided isolation using an in vitro enzyme assay with human recombinant PTP1B, (9Z)-octadec-9-enoic acid (oleic acid) could be identified as a major PTP1B inhibitor in the bark of Phellodendron amurense Rupr. (Rutaceae); it showed an IC50 value of 6.2 µM. Consistent with this inhibition of PTP1B, oleic acid was capable of enhancing insulin signalling in wild-type, but not PTP1B knockout fibroblasts. By testing a series of other fatty acids of different chain length and degree of saturation, their general PTP1B-inhibitory potential in the micromolar range was observed. More pronounced effects were associated with a longer carbon backbone and saturation of the double bonds. Therefore, our work provides first scientific evidences for the antidiabetic properties of P. amurense via a new target, effects which seem to be explainable by oleic acid. The discovery of a PTP1B inhibition by many fatty acids also adds a novel facet to the pharmacological properties of a class of compounds that is found in many food items in considerable amount and triggers speculation over their possible involvement in the feedback regulation of cellular fatty acid synthesis.
Key words
Phellodendron amurense - Rutaceae - bioguided isolation - oleic acid - protein tyrosine phosphatase 1B - fatty acids
References
- 1 Unwin N, Whiting D, Gan D, Jacqmain O, Ghyoot G. IDF Diabetes Atlas. Brussels: International Diabetes Federation; 2009
MissingFormLabel
- 2
Zhang Z Y, Lee S Y.
PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and
obesity.
Expert Opin Investig Drug.
2003;
12
223-233
MissingFormLabel
- 3
Koren S, Fantus I G.
Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity,
insulin resistance and type-2 diabetes mellitus.
Best Pract Res Clin Endocrinol.
2007;
21
621-640
MissingFormLabel
- 4 [Anonymous]. Arzneibuch der Chinesischen Medizin. Stuttgart: Deutscher Apotheker Verlag; 2009
MissingFormLabel
- 5
Uchiyama T, Kamikawa H, Ogita Z.
Anti-ulcer effect of extract from Phellodendri cortex.
Yakugaku Zasshi.
1989;
109
672-676
MissingFormLabel
- 6
Chen M L, Xian Y F, Ip S P, Tsai S H, Yang J Y, Che C T.
Chemical and biological differentiation of Cortex Phellodendri Chinensis and Cortex
Phellodendri Amurensis.
Planta Med.
2010;
76
1530-1535
MissingFormLabel
- 7
Li Y B, Zhang T J, Zhang X L, Xu H Y, Liu C X.
Chemical fingerprint analysis of Phellodendri Amurensis Cortex by ultra performance
LC/Q-TOF-MS methods combined with chemometrics.
J Sep Sci.
2010;
33
3347-3353
MissingFormLabel
- 8
Kumar A P, Graham H, Robson C, Thompson I M, Ghosh R.
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management.
Minirev Med Chem.
2010;
10
388-397
MissingFormLabel
- 9
Kim H J, Kong M K, Kim Y C.
Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy
in streptozotocin-induced diabetic rats.
BMB Rep.
2008;
41
710-715
MissingFormLabel
- 10
Tanaka T, Maeda M, Kohno H, Murakami M, Kagami S, Miyake M, Wada K.
Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus
limonoids obacunone and limonin.
Carcinogenesis.
2001;
22
193-198
MissingFormLabel
- 11
Li H Y, Guo L L, Jie S H, Liu W, Zhu J, Du W, Fan L L, Wang X J, Fu B J, Huang S.
Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation
of SDF-1 level in bone marrow stromal cells.
Biomed Pharmacother.
2008;
62
573-578
MissingFormLabel
- 12
Yu H H, Kim K J, Cha J D, Kim H K, Lee Y E, Choi N Y, You Y O.
Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin
against methicillin-resistant Staphylococcus aureus.
J Med Food.
2005;
8
454-461
MissingFormLabel
- 13
Zhou X Q, Zeng X N, Kong H, Sun X L.
Neuroprotective effects of berberine on stroke models in vitro and in vivo.
Neurosci Lett.
2008;
447
31-36
MissingFormLabel
- 14
Liu W H, Tang F T, Deng Y H, Li X J, Lan T, Zhang X Y, Huang H Q, Liu P Q.
Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial
cells cultured under high glucose condition.
Mol Cell Biochem.
2009;
325
99-105
MissingFormLabel
- 15
Sadowska J, Johansson B, Johannessen E, Friman R, Bronlarz-Press L, Rosenholm J B.
Characterization of ozonated vegetable oils by spectroscopic and chromatographic methods.
Chem Phys Lipids.
2008;
151
85-91
MissingFormLabel
- 16
Baumgartner R R, Steinmann D, Ganzera M, Atanasov A G, Dirsch V M, Stuppner H, Heiss E H.
Bioactivity-guided isolation of 1, 2, 3, 4, 6-penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor.
J Nat Prod.
2010;
73
1578-1581
MissingFormLabel
- 17
Chen C H, Zhang Y B, Huang C.
Berberine inhibits PTP1B activity and mimics insulin action.
Biochem Biophys Res Commun.
2010;
397
543-547
MissingFormLabel
- 18
Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J Y, Hu L H, Li J.
Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing
insulin receptor phosphorylation and stimulating glucose uptake.
BBA Gen Subjects.
2006;
1760
1505-1512
MissingFormLabel
- 19
Swarup G, Cohen S, Garbers D L.
Inhibition of membrane phospotyrosyl-protein phosphatase-activity by vanadate.
Biochem Bioph Res Commun.
1982;
107
1104-1109
MissingFormLabel
- 20
Iversen L F, Moller K B, Pedersen A K, Peters G H, Petersen A S, Andersen H S, Branner S, Mortensen S B, Moller N P H.
Structure determination of T cell protein-tyrosine phosphatase.
J Biol Chem.
2002;
277
19982-19990
MissingFormLabel
- 21
Zhang J W, Wu W, Li D F, Guo Y, Ding H L.
Overactivation of NF-kappa B impairs insulin sensitivity and mediates palmitate-induced
insulin resistance in C2C12 skeletal muscle cells.
Endocrine.
2010;
37
157-166
MissingFormLabel
- 22
Choi S J, Kim F, Schwartz M W, Wisse B E.
Cultured hypothalamic neurons are resistant to inflammation and insulin resistance
induced by saturated fatty acids.
Am J Physiol Endocrinol Metab.
2010;
298
E1122-E1130
MissingFormLabel
- 23
Coll T, Eyre E, Rodriguez-Calvo R, Palomer X, Sanchez R M, Merlos M, Laguna J C, Vazquez-Carrera M.
Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal
muscle cells.
J Biol Chem.
2008;
283
11107-11116
MissingFormLabel
- 24
Ruiz-Rodriguez A, Reglero G, Ibañez E.
Recent trends in the advanced analysis of bioactive fatty acids.
J Pharm Biomed.
2010;
51
305-326
MissingFormLabel
- 25
Belury M A, Gu Y H.
Conjugated linoleic acid (CLA) reduces hepatic levels of phospho-Akt in diabetic,
but not lean, ZDF rats.
FASEB J.
2003;
17
A807
MissingFormLabel
- 26
Emekli-Alturfan E, Kasikci E, Yarat A.
Effects of oleic acid on the tissue factor activity, blood lipids, antioxidant and
oxidant parameters of streptozotocin induced diabetic rats fed a high-cholesterol
diet.
Med Chem Res.
2010;
19
1011-1024
MissingFormLabel
1 Both authors contributed equally to this work.
Prof. Dr. Hermann Stuppner
Institute of Pharmacy/Pharmacognosy
University of Innsbruck
Innrain 52
6020 Innsbruck
Austria
Telefon: +43 51 25 07 53 00
Fax: +43 51 25 07 29 39
eMail: hermann.stuppner@uibk.ac.at